CAP (CEVEC's Amniocyte Production)

Primary human amniocytes immortalized by adenoviral genetic E1/pIX functions and selected for highly efficient CAP cell lines. Generated by CEVEC's proprietary technology.
Cell Type:
Embryonic/Extraembryonic Epith.
Tissue Origin:
amnion
Species:
human
Research Area:
Cancer Research/Cell Biology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V X-001 1e7 90% 80% Plasmid (general) 5 µg 100 µl I/II/2b
SE CM-138 1e6 90-95% 78% Plasmid (general) 400 ng 4D X-Unit